Sex-based prognosis in industry-sponsored advanced solid tumor trials: an individual participant data meta-analysis of survival and adverse events.
Saved in:
| Title: | Sex-based prognosis in industry-sponsored advanced solid tumor trials: an individual participant data meta-analysis of survival and adverse events. |
|---|---|
| Authors: | Chhetri R; College of Medicine and Public Health, Flinders Health and Medical Research Institute, Flinders University, Adelaide, SA, Australia., Modi ND; Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia., Menz BD; College of Medicine and Public Health, Flinders Health and Medical Research Institute, Flinders University, Adelaide, SA, Australia., Cornelisse E; College of Medicine and Public Health, Flinders Health and Medical Research Institute, Flinders University, Adelaide, SA, Australia., Postma D; College of Medicine and Public Health, Flinders Health and Medical Research Institute, Flinders University, Adelaide, SA, Australia., Kuderer NM; Advanced Cancer Research Group, Kirkland, WA, United States., Lyman GH; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA, United States.; Division of Medical Oncology, Duke University School of Medicine, Durham, NC, United States., Swain SM; Georgetown Lombardi Comprehensive Cancer Center, Georgetown University Medical Center and Genetic Medicine, MedStar Health, Washington, DC, United States., Li LX; College of Medicine and Public Health, Flinders Health and Medical Research Institute, Flinders University, Adelaide, SA, Australia., Abuhelwa AY; Department of Pharmacy Practice and Pharmacotherapeutics, College of Pharmacy, University of Sharjah, Sharjah, United Arab Emirates., McKinnon RA; College of Medicine and Public Health, Flinders Health and Medical Research Institute, Flinders University, Adelaide, SA, Australia., Vatandoust S; College of Medicine and Public Health, Flinders Health and Medical Research Institute, Flinders University, Adelaide, SA, Australia.; Flinders Centre for Innovation in Cancer, Department of Medical Oncology, Flinders Medical Centre, Flinders University, Bedford Park, SA, Australia., Kichenadasse G; College of Medicine and Public Health, Flinders Health and Medical Research Institute, Flinders University, Adelaide, SA, Australia.; Flinders Centre for Innovation in Cancer, Department of Medical Oncology, Flinders Medical Centre, Flinders University, Bedford Park, SA, Australia., Rowland A; College of Medicine and Public Health, Flinders Health and Medical Research Institute, Flinders University, Adelaide, SA, Australia., Sorich MJ; College of Medicine and Public Health, Flinders Health and Medical Research Institute, Flinders University, Adelaide, SA, Australia., Hopkins AM; College of Medicine and Public Health, Flinders Health and Medical Research Institute, Flinders University, Adelaide, SA, Australia. |
| Source: | Journal of the National Cancer Institute [J Natl Cancer Inst] 2026 Jul 01; Vol. 118 (7), pp. 1219-1228. |
| Publication Type: | Journal Article; Meta-Analysis |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
